Complexes [Pd{C,N-Ar{C(Me)=NOH}-2}(μ-Cl)](2) (1) with Ar = C(6)H(4), C(6)H(3)NO(2)-5 or C(6)H(OMe)(3)-4,5,6, were obtained from the appropriate oxime, Li(2)[PdCl(4)] and NaOAc. They reacted with neutral monodentate C-, P- or N-donor ligands (L), with [PPN]Cl ([PPN] = Ph(3)P=N=PPh(3)), with Tl(acac) (acacH = acetylacetone), or with neutral bidentate ligands N^N (tetramethylethylenediamine (tmeda), 4,4'-di-tert-butyl-2,2'-bipyridine ((t)Bubpy)) in the presence of AgOTf or AgClO(4) to afford complexes of the types [Pd{C,N-Ar{C(Me)=NOH}-2}Cl(L)] (2), [PPN][Pd{C,N-Ar{C(Me)=NOH}-2}Cl(2)] (3), [Pd{C,N-Ar{C(Me)=NOH}-2}(acac)] (4) or [Pd{C,N-Ar{C(Me)=NOH}-2}(N^N)]X (X = OTf, ClO(4)) (5), respectively. Complexes 1 reacted with bidentate N^N ligands in the presence of a base to afford mononuclear zwitterionic oximato complexes [Pd{C,N-Ar{C(Me)=NO}-2}(N^N)] (6). Dehydrochlorination of complexes 2 by a base yielded dimeric oximato complexes of the type [Pd{μ-C,N,O-Ar{C(Me)[double bond, length as m-dash]NO}-2}L](2) (7). The insertion of XyNC into the Pd-C(aryl) bond of complex 2 produced the mononuclear iminoaryloxime derivative [Pd{C,N-C(=NXy)Ar{C(Me)=NOH}-2}Cl(CNXy)] (8) which, in turn, reacted with [AuCl(SMe(2))] to give [Pd{μ-N,C,N-C(=NXy)Ar{C(Me)=NOH}-2}Cl](2) (9) with loss of XyNC. Some of these complexes are, for any metal, the first containing cyclometalated aryloximato (6, 7) or iminoaryloxime (8, 9) ligands. Various crystal structures of complexes of the types 2, 3, 6, 7, 8 and 9 have been determined.